Construction of the ESKD Life Plan
ESKD 生命计划的构建
基本信息
- 批准号:10353406
- 负责人:
- 金额:$ 11.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAffectAreaArteriovenous fistulaAttitudeBlood VesselsCaringCase ManagementClinicalClinical Practice GuidelineCollaborationsComplicationConflict (Psychology)DataDecision MakingDevelopmentDialysis procedureEducational MaterialsEnd stage renal failureFaceFailureFeelingFistulaFoundationsFundingFutureGoalsGrantGuidelinesHealthcare SystemsHemodialysisHospitalizationIndividualInfrastructureInterdisciplinary StudyInterviewKidneyKnowledgeLifeLongevityMalignant NeoplasmsMedicalMedicareMethodsModelingNatureOutcomeParticipantPatient PreferencesPatient RightsPatientsPeer ReviewPhysiciansPopulationProceduresProcessProviderQuality of CareQuality of lifeRecommendationRenal functionResearchSourceSpecific qualifier valueStructureSurgeonTestingTimeTrainingUpdateVascular GraftVisioncare providersexperiencefield studyindividual patientmedical specialtiesmultidisciplinarynoveloperationpatient engagementpatient orientedpreferenceprototyperadiologistshared decision makingtool
项目摘要
PROJECT SUMMARY/ABSTRACT
Decisions about vascular access in patients with end-stage kidney disease (ESKD) who are hemodialysis
dependent can strongly influence clinical outcomes of vascular access longevity, need for revision procedures,
repeat access operations and hospitalizations which in turn affect patients' quality of life. Addressing this, the
pending update of the National Kidney Foundation Dialysis Outcomes Quality Initiative (K-DOQI) Clinical
Practice Guideline for Vascular Access recommends construction and regular update of an individualized
ESKD Life-Plan for each patient. Such vascular access Life-Plans encompass a specific plan for all of the
vascular accesses for an individual patient for the remainder of the patient’s hemodialysis-dependent life. Life-
Plans are to be developed by the provider team in conjunction with the patient, within a multidisciplinary team
framework. However, implementing K-DOQI-recommended Life-Plans can require considerable infrastructure
and may face significant barriers, as the concept of such an ESKD Life-Plan is entirely novel both to patients
and providers. The goal of the proposed research is to ascertain providers', patients' and relevant
stakeholders’ attitudes and preferences for how the multidisciplinary provider-patient discussions should be
conducted.
To overcome barriers to implementing K-DOQI guidelines, relevant patients and providers will be engaged in co-
developing a toolkit for ESKD Life-Plan implementation focused on patient engagement, shared decision-making
and barriers and facilitators to multidisciplinary collaboration. First, qualitative individual semi-structured
interviews with approximately 55 patients and providers will be used, enabling a) unrestricted exploration of the
topic; and b) participants to express attitudes and preferences in their own words. These data will then be used
to develop a prototype Life-Plan implementation toolkit that accommodates diverse patient preferences and
healthcare systems, and perform its initial field testing and peer review. This will inform future grant-funded
implementation testing to determine the toolkit's efficacy and utility in enabling and facilitating transition to the
new vascular access paradigm.
The Specific Aims are to:
1: Determine the attitudes and preferences of relevant patients and providers with respect to degree and
nature of their own involvement in shared decision-making and development of the ESKD Life-Plan.
2: Develop and perform initial field testing and peer review of a Life-Plan implementation toolkit that empowers
patients to engage in the vascular access shared decision-making process and offers methods to providers to
overcome challenges of the multidisciplinary team approach.
项目总结/摘要
终末期肾病(ESKD)血液透析患者血管通路的决定
依赖性可强烈影响血管通路寿命的临床结局,是否需要翻修手术,
重复手术和住院,这反过来又影响了患者的生活质量。针对这一点,
国家肾脏基金会透析结果质量倡议(K-DOQI)临床
血管通路实践指南建议构建和定期更新个性化的
每位患者的ESKD生命计划。这样的血管通路生命计划包括针对所有患者的特定计划。
在患者的血液透析依赖性生命的剩余时间内为个体患者提供血管通路。生活-
计划将由提供者团队与患者一起在多学科团队中制定
框架.然而,实施K-DOQI推荐的生命计划可能需要大量的基础设施
并且可能面临重大障碍,因为这种ESKD生命计划的概念对患者和患者都是全新的,
和供应商。拟议研究的目标是确定提供者,患者和相关的
利益相关者的态度和偏好的多学科提供者-患者的讨论应该是
进行。
为了克服实施K-DOQI指南的障碍,相关患者和提供者将共同参与,
开发ESKD生命计划实施工具包,重点关注患者参与、共同决策
以及多学科合作的障碍和促进因素。第一,定性个体半结构化
将使用约55名患者和提供者的访谈,使a)不受限制地探索
主题;以及B)参与者用自己的话表达态度和偏好。这些数据将用于
开发一个原型生命计划实施工具包,以适应不同的患者偏好,
医疗保健系统,并进行初步的实地测试和同行评审。这将为未来的赠款供资提供信息。
执行情况测试,以确定工具包在促成和促进向
新的血管通路范例。
具体目标是:
1:确定相关患者和医疗服务提供者对程度和
他们自己参与共同决策和制定ESKD生活计划的性质。
2:制定和执行初步的实地测试和同行审查的生命计划执行工具包,
患者参与血管通路共享决策过程,并为供应商提供方法,
克服多学科团队方法的挑战。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline.
- DOI:10.1007/s11606-023-08290-5
- 发表时间:2023-11
- 期刊:
- 影响因子:5.7
- 作者:Keller, Michelle S.;Mavilian, Christine;Altom, Keaton L.;Erickson, Kevin F.;Drudi, Laura M.;Woo, Karen
- 通讯作者:Woo, Karen
Thrombus Extension after Great Saphenous Vein Mechanochemical Ablation.
- DOI:10.1016/j.avsg.2021.03.015
- 发表时间:2021-08
- 期刊:
- 影响因子:1.5
- 作者:Rebuffatti M;Chan K;Woo K
- 通讯作者:Woo K
Patient Frailty and Functional Use of Hemodialysis Vascular Access: A Retrospective Study of the US Renal Data System.
- DOI:10.1053/j.ajkd.2021.10.011
- 发表时间:2022-07
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Surgeon Factors Have a Larger Effect on Vascular Access Type and Outcomes than Patient Factors.
- DOI:10.1016/j.jss.2021.02.046
- 发表时间:2021-09
- 期刊:
- 影响因子:0
- 作者:Copeland TP;Lawrence PF;Woo K
- 通讯作者:Woo K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen Woo其他文献
Karen Woo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen Woo', 18)}}的其他基金
Improving the patient experience of hemodialysis vascular access decision making
改善血液透析血管通路决策的患者体验
- 批准号:
10522654 - 财政年份:2022
- 资助金额:
$ 11.7万 - 项目类别:
Comparing surgical and endovascular arteriovenous fistula creation
手术与血管内动静脉内瘘创建的比较
- 批准号:
10709628 - 财政年份:2022
- 资助金额:
$ 11.7万 - 项目类别:
Comparing surgical and endovascular arteriovenous fistula creation
手术与血管内动静脉内瘘创建的比较
- 批准号:
10586937 - 财政年份:2022
- 资助金额:
$ 11.7万 - 项目类别:
Improving the patient experience of hemodialysis vascular access decision making
改善血液透析血管通路决策的患者体验
- 批准号:
10693330 - 财政年份:2022
- 资助金额:
$ 11.7万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 11.7万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 11.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 11.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.7万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 11.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.7万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 11.7万 - 项目类别:
Standard Grant














{{item.name}}会员




